STOCK TITAN

Natera (NTRA) director logs RSU grant and stock sales near $228 per share

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Natera, Inc. reported insider activity by a company director involving both equity awards and stock sales. On 10/31/2025, the director received 132 Restricted Stock Units (RSUs) in lieu of a $23,750 quarterly cash retainer for board service, and these RSUs were fully vested at issuance, with each RSU representing one share of common stock.

Following this grant, the director held 68,761 common shares directly. On 12/12/2025, the director sold several blocks of Natera common stock: 14,372 shares at a weighted average price of $226.6174, 21,910 shares at $227.3532, 11,987 shares at $228.4858, and 150 shares at $229.095, all in multiple trades within narrow price ranges. After these transactions, the director directly owned 20,342 Natera shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ROSENMAN HERM

(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TX 78753

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/31/2025 A 132(1) A (2) 68,761 D
Common Stock 12/12/2025 S 14,372 D $226.6174(3) 54,389 D
Common Stock 12/12/2025 S 21,910 D $227.3532(4) 32,479 D
Common Stock 12/12/2025 S 11,987 D $228.4858(5) 20,492 D
Common Stock 12/12/2025 S 150 D $229.095 20,342 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $23,750 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.
2. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.9450 to $226.9350 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.95 to $227.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.00 to $228.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Vincent Fontanilla, Attorney-in-Fact 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Natera (NTRA) report for this director?

The director received 132 RSUs on 10/31/2025 in lieu of a cash retainer and then sold multiple blocks of Natera common stock on 12/12/2025 at prices around $226–$229 per share.

How many RSUs did the Natera (NTRA) director receive and for what compensation?

The director was issued 132 Restricted Stock Units (RSUs) in lieu of quarterly retainer fees of $23,750 for serving on Natera’s Board of Directors, and these RSUs were fully vested at issuance.

At what prices did the Natera (NTRA) director sell common stock?

On 12/12/2025, the director sold Natera common stock at weighted average prices of $226.6174, $227.3532, $228.4858, and $229.095, with individual trades occurring within stated ranges between about $225.9450 and $228.99 per share.

How many Natera (NTRA) shares does the director own after these transactions?

After the reported RSU grant and stock sales, the director directly beneficially owned 20,342 shares of Natera common stock.

Were the RSUs granted to the Natera (NTRA) director vested immediately?

Yes. The 132 RSUs granted to the director were stated to be fully vested at the time of issuance, and each RSU represents a contingent right to receive one share of Natera common stock.

Did the Form 4 report any derivative securities for the Natera (NTRA) director?

The report included a table for derivative securities, but no derivative securities transactions or holdings were listed for the director in that table.

Natera Inc

NASDAQ:NTRA

View NTRA Stock Overview

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

28.02B
136.78M
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN